Stocks / AMEX / ImmunoCellular Therapeutics, Ltd.

ImmunoCellular Therapeutics, Ltd.

Our Opinion

ImmunoCellular Therapeutics is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products, research and therapies.

Evidence:

This press release specifically mentions use of animal testing:
http://investors.imuc.com/releasedetail.cfm?releaseid=872320

Company Description

ImmunoCellular Therapeutics, Ltd.  is a Los Angeles-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. The phase 3 registrational trial of lead product candidate, ICT-107, a patient-specific, dendritic cell-based immunotherapy targeting multiple tumor-associated antigens on glioblastoma stem cells, has been initiated.

 

Company website:  http://www.imuc.com